Aberdeen Group plc Has $36.10 Million Stock Position in Amdocs Limited $DOX

Key Points

• Aberdeen Group plc has reduced its holdings in Amdocs Limited by 7.8%, now owning 394,523 shares valued at approximately $36 million.
• Amdocs has received an analyst upgrade, with a consensus rating of "Buy" and a target price of $105.33.
• The company declared a quarterly dividend of $0.527, with a dividend yield of 2.4%, to be paid out on October 31st.

Aberdeen Group plc decreased its stake in shares of Amdocs Limited (NASDAQ:DOX - Free Report) by 7.8% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 394,523 shares of the technology company's stock after selling 33,437 shares during the period. Aberdeen Group plc owned approximately 0.35% of Amdocs worth $36,099,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Farther Finance Advisors LLC boosted its holdings in shares of Amdocs by 17.5% during the first quarter. Farther Finance Advisors LLC now owns 988 shares of the technology company's stock worth $90,000 after purchasing an additional 147 shares during the period. Corbyn Investment Management Inc. MD raised its position in shares of Amdocs by 0.4% in the first quarter. Corbyn Investment Management Inc. MD now owns 38,866 shares of the technology company's stock valued at $3,556,000 after purchasing an additional 152 shares during the period. PNC Financial Services Group Inc. raised its position in shares of Amdocs by 3.5% in the first quarter. PNC Financial Services Group Inc. now owns 5,247 shares of the technology company's stock valued at $480,000 after purchasing an additional 177 shares during the period. Denali Advisors LLC grew its stake in shares of Amdocs by 3.6% in the first quarter. Denali Advisors LLC now owns 5,810 shares of the technology company's stock worth $532,000 after acquiring an additional 200 shares during the last quarter. Finally, Tower Research Capital LLC TRC grew its stake in shares of Amdocs by 55.0% in the fourth quarter. Tower Research Capital LLC TRC now owns 586 shares of the technology company's stock worth $50,000 after acquiring an additional 208 shares during the last quarter. Institutional investors and hedge funds own 92.02% of the company's stock.

Amdocs Stock Up 1.9%

NASDAQ:DOX traded up $1.63 during trading hours on Friday, reaching $88.24. 151,391 shares of the stock were exchanged, compared to its average volume of 715,897. Amdocs Limited has a twelve month low of $78.61 and a twelve month high of $95.41. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.22 and a quick ratio of 1.16. The firm has a 50 day moving average of $89.22 and a 200 day moving average of $88.76. The stock has a market cap of $9.96 billion, a PE ratio of 17.91, a PEG ratio of 1.59 and a beta of 0.51.

Amdocs (NASDAQ:DOX - Get Free Report) last released its quarterly earnings results on Wednesday, August 6th. The technology company reported $1.72 earnings per share for the quarter, topping analysts' consensus estimates of $1.71 by $0.01. Amdocs had a return on equity of 19.66% and a net margin of 11.94%.The firm had revenue of $1.14 billion during the quarter, compared to the consensus estimate of $1.13 billion. During the same quarter in the prior year, the firm posted $1.62 EPS. The business's revenue was down 8.4% on a year-over-year basis. On average, equities analysts expect that Amdocs Limited will post 6.21 earnings per share for the current year.

Amdocs Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Tuesday, September 30th will be paid a dividend of $0.527 per share. The ex-dividend date is Tuesday, September 30th. This represents a $2.11 dividend on an annualized basis and a dividend yield of 2.4%. Amdocs's dividend payout ratio is currently 42.80%.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on DOX shares. Wolfe Research started coverage on shares of Amdocs in a research note on Tuesday, July 8th. They set an "outperform" rating on the stock. Wall Street Zen upgraded shares of Amdocs from a "hold" rating to a "buy" rating in a research note on Sunday, August 10th. Four equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the company currently has a consensus rating of "Buy" and an average target price of $105.33.

Amdocs Company Profile

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.